tert-Butyl trans-2-amino-6-azaspiro[3.4]octane-6-carboxylate

Catalog No. :
ACQRAX046
CAS No. :
1932303-76-8
Molecular Formula :
C12H22N2O2
Molecular Weight :
226.32

IUPAC Name:tert-butyl (2r,4s)-2-amino-6-azaspiro[3.4]octane-6-carboxylate

tert-Butyl trans-2-amino-6-azaspiro[3.4]octane-6-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$576.00Login to see priceIn stockInquiry
250mg95%$920.00Login to see priceIn stockInquiry
500mg95%$1534.00Login to see priceIn stockInquiry
1g95%$2299.00Login to see priceIn stockInquiry
5g95%$6896.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl trans-2-amino-6-azaspiro[3.4]octane-6-carboxylate
IUPAC Nametert-butyl (2r,4s)-2-amino-6-azaspiro[3.4]octane-6-carboxylate
MDL No.MFCD27997369
Molecular FormulaC12H22N2O2
Molecular Weight226.32
SMILESO=C(N(CC1)C[C@@]21C[C@@H](N)C2)OC(C)(C)C
InChI KeyTWNDWKDXPSDFLL-WVSHTKLVSA-N
Synonymtert-butyl trans-2-amino-6-azaspiro[3.4]octane-6-carboxylate;trans-6-Boc-2-amino-6-azaspiro[3.4]octane;tert-butyl trans-2-amino-6-azaspiro[3.4]octane-6-carboxylate - [B84257]
CAS No.1932303-76-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362-P501

Synthetic Route by SureRoute

1. ACQRAX046 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQRAX046 route product structure diagram
    ACQRAX0461932303-76-8 In Stock
Inquiry

2. ACQRAX046 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQRAX046 route product structure diagram
    ACQRAX0461932303-76-8 In Stock
Inquiry

Comments (0)